Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Prestige Consumer Healthcare (PBH) 10K Form and Latest SEC Filings 2026

Prestige Consumer Healthcare logo
$46.61 -0.14 (-0.30%)
Closing price 05/18/2026 03:59 PM Eastern
Extended Trading
$46.60 -0.01 (-0.03%)
As of 07:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Prestige Consumer Healthcare SEC Filings & Recent Activity

Prestige Consumer Healthcare (NYSE:PBH) has submitted 313+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Prestige Consumer Healthcare's financial statements. The most recent filing was a Form 10-K submitted on May 14, 2026.

Form 4
Prestige Consumer Healthcare Inc. Reports Ownership Change on May. 11, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Prestige Consumer Healthcare Files Current Report on May. 13, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-K
Prestige Consumer Healthcare Files Annual Report on May. 14, 2026

The 10-K contains Prestige Consumer Healthcare's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

Prestige Consumer Healthcare SEC Filing History

Browse Prestige Consumer Healthcare's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/14/2026 3:32 PM
Prestige Consumer Healthcare (1295947) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/13/2026 3:35 PM
Prestige Consumer Healthcare (1295947) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2026 3:01 PM
Lombardi Ronald M. (1507111) Reporting
Prestige Consumer Healthcare (1295947) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 3:02 PM
Prestige Consumer Healthcare (1295947) Issuer
Sacco Christine (1507301) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 3:03 PM
Prestige Consumer Healthcare (1295947) Issuer
Zerillo Jeffrey (1749501) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 8:38 AM
Prestige Consumer Healthcare (1295947) Subject
Zerillo Jeffrey (1749501) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2026 3:02 PM
Prestige Consumer Healthcare (1295947) Issuer
Zerillo Jeffrey (1749501) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2026 1:32 PM
Prestige Consumer Healthcare (1295947) Subject
Zerillo Jeffrey (1749501) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2026 4:15 PM
Lombardi Ronald M. (1507111) Reporting
Prestige Consumer Healthcare (1295947) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2026 4:15 PM
Mekhail Adel (1776953) Reporting
Prestige Consumer Healthcare (1295947) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2026 4:16 PM
Prestige Consumer Healthcare (1295947) Issuer
Zerillo Jeffrey (1749501) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2026 4:16 PM
P'Pool William (1455752) Reporting
Prestige Consumer Healthcare (1295947) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2026 4:17 PM
Prestige Consumer Healthcare (1295947) Issuer
Sacco Christine (1507301) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2026 11:27 AM
Prestige Consumer Healthcare (1295947) Subject
Zerillo Jeffrey (1749501) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2026 3:03 PM
Prestige Consumer Healthcare (1295947) Issuer
Zerillo Jeffrey (1749501) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2026 3:04 PM
Prestige Consumer Healthcare (1295947) Issuer
Sacco Christine (1507301) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2026 12:03 PM
Prestige Consumer Healthcare (1295947) Subject
Zerillo Jeffrey (1749501) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/30/2026 11:13 AM
Prestige Consumer Healthcare (1295947) Subject
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Form SCHEDULE 13G
04/29/2026 1:51 PM
Prestige Consumer Healthcare (1295947) Subject
VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by
Form SCHEDULE 13G
03/27/2026 10:21 AM
Prestige Consumer Healthcare (1295947) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/20/2026 5:15 AM
Prestige Consumer Healthcare (1295947) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2026 9:52 AM
ARIEL INVESTMENTS, LLC (936753) Filed by
Prestige Consumer Healthcare (1295947) Subject
Form SCHEDULE 13G/A
02/11/2026 9:28 AM
Prestige Consumer Healthcare (1295947) Subject
Zerillo Jeffrey (1749501) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2026 5:04 AM
Prestige Consumer Healthcare (1295947) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2026 5:09 AM
Prestige Consumer Healthcare (1295947) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/02/2025 3:43 PM
Prestige Consumer Healthcare (1295947) Issuer
Zerillo Jeffrey (1749501) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2025 10:24 AM
Prestige Consumer Healthcare (1295947) Subject
Zerillo Jeffrey (1749501) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2025 12:04 PM
Prestige Consumer Healthcare (1295947) Subject
Zerillo Jeffrey (1749501) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2025 12:08 PM
BYOM JOHN E (1202329) Reporting
Prestige Consumer Healthcare (1295947) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2025 10:24 AM
ARIEL INVESTMENTS, LLC (936753) Filed by
Prestige Consumer Healthcare (1295947) Subject
Form SCHEDULE 13G
11/06/2025 5:11 AM
Prestige Consumer Healthcare (1295947) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2025 5:03 AM
Prestige Consumer Healthcare (1295947) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025 5:07 AM
Prestige Consumer Healthcare (1295947) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025 5:15 AM
Prestige Consumer Healthcare (1295947) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Prestige Consumer Healthcare SEC Filings - Frequently Asked Questions

Prestige Consumer Healthcare (PBH) has submitted 313+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

Prestige Consumer Healthcare's fiscal year ends on March 31. The company typically files its 10-K annual report by the end of May, covering the prior fiscal year's financial results. Key financial data from these reports is available on Prestige Consumer Healthcare's financial statements page.

The most recent filing was a Form 10-K submitted on May 14, 2026. This was the company's annual report for fiscal year 2025.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:PBH) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners